BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)

$1.06 -0.02 (-1.8519%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 86

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) News Sources

BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions

08-04-2026

yahoo.com

BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting

01-04-2026

yahoo.com

How The BioXcel Therapeutics (BTAI) Story Is Shifting With BXCL501 Hopes And Dilution Risks

29-03-2026

yahoo.com

BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI® Approval in Outpatient Setting

27-03-2026

yahoo.com

How The BioXcel Therapeutics (BTAI) Story Is Shifting With Dilution Risks And Funding Needs

12-03-2026

yahoo.com

BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering

11-03-2026

yahoo.com

BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering

10-03-2026

yahoo.com

BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal

05-03-2026

yahoo.com

BioXcel Therapeutics to Host Virtual Roundtable Featuring Leading Medical Experts Addressing Latest Developments in Treatment of Acute Agitation in Alzheimer’s Dementia

19-02-2026

yahoo.com

BioXcel Therapeutics Completes Market Opportunity Assessment and Advances Commercialization Plans for IGALMI® in the At-Home Setting

12-02-2026

yahoo.com

BTAI stock
BTAI stock price
BTAI stock price today
BTAI stock prediction
BTAI earnings date
BTAI news
BTAI price
BTAI share
BTAI share price
BTAI shares
BTAI ceo
BTAI premarket
$BTAI
BTAI ticker
BTAI after hours
BTAI stock
BTAI stock price
BTAI stock price today
BTAI stock prediction
BTAI earnings date
BTAI news
BTAI price
BTAI share
BTAI share price
BTAI shares
BTAI ceo
BTAI premarket
$BTAI
BTAI ticker
BTAI after hours

BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) Sentiment Trend

View FAQ

BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) FAQs

toggle

What is the current price of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)?

The current price of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) is $1.06.


toggle

BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) absolute price change since previous trading day?

The absolute price change of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) since the previous trading day is $-0.02.


toggle

BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) percentage price change since previous trading day?

The percentage price change of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) since the previous trading day is -1.8519%.


toggle

What is the most recent average sentiment score for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)?

The most recent average sentiment score for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) is 86 out of 100.


toggle

What is the most recent average sentiment for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)?

The most recent sentiment for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) is .


SEC-8K** Filing Available For BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.